Flexion Therapeutics
FLXN
#7202
Rank
โ‚ฌ0.40 B
Marketcap
7,98ย โ‚ฌ
Share price
0.00%
Change (1 day)
7,778.87%
Change (1 year)

Revenue for Flexion Therapeutics (FLXN)

Revenue in 2021 (TTM): โ‚ฌ84.54 Million

According to Flexion Therapeutics 's latest financial reports the company's current revenue is โ‚ฌ87.89 Million. In 2020 the company made a revenue of โ‚ฌ74.89 Million an increase over the revenue in the year 2019 that were of โ‚ฌ63.86 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Flexion Therapeutics from 2018 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ84.54 M12.89%
2020โ‚ฌ74.89 M17.26%
2019โ‚ฌ63.86 M223.91%
2018โ‚ฌ19.71 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ80.66 B 91,681.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ54.96 B 62,435.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
โ‚ฌ65.97 M-24.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
โ‚ฌ0.62 B 613.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
โ‚ฌ0.56 M-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Ampio Pharmaceuticals
AMPE
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
โ‚ฌ6.24 M-92.89%๐Ÿ‡บ๐Ÿ‡ธ USA